Ulta Gets A Touch-Up: JPMorgan Lifts Price Target Ahead Of Q1 Earnings

JPMorgan analyst Christopher Horvers reiterated an Overweight rating on Ulta Beauty (ULTA) and raised the price target to $477 from $475, anticipating improved Q1 earnings driven by Ulta's mass-prestige product mix and a stabilizing beauty market. Ulta's Q1 earnings report, due May 29 post-market, is expected to show improving comparable sales trends, supported by promotional events and consistent consumer behavior, with quarter-to-date trends showing modest improvement of approximately 50 basis points based on Nielsen and Circana data.

Analysis

JPMorgan has reiterated its Overweight rating on Ulta Beauty (ULTA) and marginally increased its price target to $477 from $475, signaling confidence ahead of the company's first-quarter earnings release scheduled for May 29, post-market. The analyst anticipates an earnings uplift driven by Ulta's distinctive blend of mass and prestige products, which is expected to capitalize on a stabilizing beauty market projected to normalize to a 3%-4% growth trajectory, allowing Ulta to potentially gain market share. This positive outlook is supported by management's earlier comments on improving comparable sales trends from a nearly flat Q4, buoyed by its semi-annual event and more stable consumer behavior, a sentiment echoed by CEO Kecia Steelman who highlighted consistent consumer activity and strong promotional period performance despite softer overall engagement in quieter times. Quarter-to-date data from Nielsen and Circana indicate a modest 50 basis point improvement in trends, with sequential strengthening from January through March, and insights from competitors Coty and Estee Lauder suggesting April outperformed March, leading the analyst to revise their comparable sales forecast upwards to 0.7%. While Ulta's shares were recently trading down 1.38% at $405.04, management anticipates comparable sales in Q2 to be similar to Q1, benefiting from easier year-over-year comparisons in Q2 and Q3, alongside abating market share pressures and enhanced operational execution.

Key Decisions for Investors

• Investors may consider the recent share price decline as a potential buying opportunity, given the analyst's reaffirmed Overweight rating and expectations for enhanced earnings and market share expansion for Ulta Beauty.
• It is critical to meticulously review Ulta's upcoming Q1 earnings report on May 29 for validation of the anticipated improvement in comparable sales, details on margin performance, and management's comprehensive guidance for Q2 and the fiscal year.
• The prospect of multiple expansion, as suggested by the analyst, warrants attention, contingent upon Ulta's successful execution of its differentiated product strategy and its ability to capitalize on the normalizing beauty market environment and improve consumer engagement.